Page last updated: 2024-09-03

marimastat and pyrazines

marimastat has been researched along with pyrazines in 3 studies

Compound Research Comparison

Studies (marimastat)	Trials (marimastat)	Recent Studies (post-2010) (marimastat)	Studies (pyrazines)	Trials (pyrazines)	Recent Studies (post-2010) (pyrazines)
215	28	53	12,165	1,373	5,747

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hande, KR; Nelson, AR; Rothenberg, ML	1
Eckhardt, SG; Hidalgo, M	1
Howes, JM; Laing, GD; Theakston, RD	1

Reviews

1 review(s) available for marimastat and pyrazines

Article	Year
Development of matrix metalloproteinase inhibitors in cancer therapy. Journal of the National Cancer Institute, 2001, Feb-07, Volume: 93, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biphenyl Compounds; Clinical Trials as Topic; Drugs, Investigational; Enzyme Inhibitors; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Neoplasms; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Tetracycline; Tetracyclines; Thiophenes	2001

Article

Year

Development of matrix metalloproteinase inhibitors in cancer therapy.

Journal of the National Cancer Institute, 2001, Feb-07, Volume: 93, Issue:3

Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biphenyl Compounds; Clinical Trials as Topic; Drugs, Investigational; Enzyme Inhibitors; Humans; Hydroxamic Acids; Imidazoles; Matrix Metalloproteinase Inhibitors; Neoplasms; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Tetracycline; Tetracyclines; Thiophenes

2001

Other Studies

2 other study(ies) available for marimastat and pyrazines

Article	Year
New drugs on the horizon: matrix metalloproteinase inhibitors. Stem cells (Dayton, Ohio), 1999, Volume: 17, Issue:4 Topics: Antineoplastic Agents; Azepines; Biphenyl Compounds; Humans; Hydroxamic Acids; Metalloendopeptidases; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Thiophenes	1999
Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators. Toxicon : official journal of the International Society on Toxinology, 2007, Volume: 49, Issue:5 Topics: Animals; Biphenyl Compounds; Chelating Agents; Chromatography, Gel; Chromatography, Liquid; Edetic Acid; Egtazic Acid; Ethylenediamines; Evaluation Studies as Topic; Hemorrhage; Hydroxamic Acids; Metalloproteases; Mice; Molecular Structure; Organic Chemicals; Phenylbutyrates; Protein Kinase Inhibitors; Pyrazines; Snake Bites; Statistics, Nonparametric; Sulfonamides; Viper Venoms	2007

Article

Year

New drugs on the horizon: matrix metalloproteinase inhibitors.

Stem cells (Dayton, Ohio), 1999, Volume: 17, Issue:4

Topics: Antineoplastic Agents; Azepines; Biphenyl Compounds; Humans; Hydroxamic Acids; Metalloendopeptidases; Organic Chemicals; Phenylalanine; Phenylbutyrates; Protease Inhibitors; Pyrazines; Sulfonamides; Thiophenes

1999

Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators.

Toxicon : official journal of the International Society on Toxinology, 2007, Volume: 49, Issue:5

Topics: Animals; Biphenyl Compounds; Chelating Agents; Chromatography, Gel; Chromatography, Liquid; Edetic Acid; Egtazic Acid; Ethylenediamines; Evaluation Studies as Topic; Hemorrhage; Hydroxamic Acids; Metalloproteases; Mice; Molecular Structure; Organic Chemicals; Phenylbutyrates; Protein Kinase Inhibitors; Pyrazines; Snake Bites; Statistics, Nonparametric; Sulfonamides; Viper Venoms

2007